Ronan E. O'Carroll, Lesley M. McGregor, Vivien Swanson, George Masterton, Peter C. Hayes – 13 June 2006 – This study assessed adherence to medication after liver transplantation and consisted of 2 components: a retrospective audit involving the examination of the Scottish national database, and a preliminary study assessing psychological factors implicated in poor adherence.
Chris Rhee, Kiran Narsinh, Robert S. Venick, Ricardo A. Molina, Visal Nga, Rita Engelhardt, Martín G. Martín – 1 June 2006 – The current United Network for Organ Sharing (UNOS) policy is to allocate liver grafts to pediatric patients with chronic liver disease based on the pediatric end‐stage liver disease (PELD) scoring system, while children with fulminant hepatic failure may be urgently listed as Status 1a.
Surakit Pungpapong, Salvador Alvarez, Walter C. Hellinger, David J. Kramer, Darrin L. Willingham, Julio C. Mendez, Justin H. Nguyen, Winston R. Hewitt, Jaime Aranda‐Michel, Denise M. Harnois, Barry G. Rosser, Christopher B. Hughes, Hani P. Grewal, Raj Satyanarayana, Rolland C. Dickson, Jeffrey L. Steers, Andrew P. Keaveny – 1 June 2006 – Peritonitis occurring after liver transplantation (PLT) has been poorly characterized to date. The aims of this study were to define the incidence, risk factors, microbiology profiles, and outcome of nonlocalized PLT.
Jérôme Dumortier, Marie‐Claude Gagnieu, Janine Salandre, Olivier Guillaud, Philipe Guillem, Mustapha Adham, Olivier Boillot – 1 June 2006 – Gastrointestinal (GI) disorders are one of the main adverse events in patients treated by mycophenolic acid (MPA).
Angelo Luca, Roberto Miraglia, Settimo Caruso, Mariapina Milazzo, Bruno Gidelli, Jaime Bosch – 1 June 2006 – The specific contribution of splenic blood inflow to portal hypertension in patients with cirrhosis is still unclear. In this study, we investigated this contribution by assessing the hemodynamic effects of transient splenic artery occlusion.
Jacob Alexander, Ajit P. Limaye, Cynthia W. Ko, Mary P. Bronner, Kris V. Kowdley – 1 June 2006 – Invasive fungal infection is a serious complication of orthotopic liver transplantation, but its risk factors remain incompletely defined. Iron overload has already been associated with increased risk of fungal infections, but it has not yet been assessed as a risk factor in liver transplantation. We retrospectively studied a cohort of 153 consecutive patients who underwent their first liver transplantation at a single center and who survived at least 7 days after transplantation.
Hubert Hetz, Peter Faybik, Gabriela Berlakovich, Amir Baker, Andreas Bacher, Christopher Burghuber, Sigrid E. Sandner, Heinz Steltzer, Claus Georg Krenn – 1 June 2006 – Early allograft dysfunction (EAD) after orthotopic liver transplantation (OLT) causes marked morbidity and mortality. We conducted a prospective pilot study to assess the safety and efficacy of molecular adsorbent recirculating system (MARS) in treatment of EAD after OLT.
Gabriele I. Kirchner, Kinan Rifai, Tobias Cantz, Bjoern Nashan, Christoph Terkamp, Thomas Becker, Christian Strassburg, Hannelore Barg‐Hock, Siegfried Wagner, Rainer Lück, Juergen Klempnauer, Michael P. Manns – 1 June 2006 – In advanced stages of polycystic liver disease, often associated with polycystic kidney disease, a curative therapy is liver or combined liver‐kidney transplantation. However, little is known about long‐term outcome and quality of life.
Nguyen L. Toan, Le H. Song, Peter G. Kremsner, Dinh N. Duy, Vu Q. Binh, Bernd Koeberlein, Stefan Kaiser, Reinhard Kandolf, Joseph Torresi, C.‐Thomas Bock – 25 May 2006 – Eight genotypes (A‐H) of hepatitis B virus (HBV) have been identified. However, the impact of different genotypes on the clinical course of hepatitis B infection remains controversial. We investigated the frequency and clinical outcome of HBV genotypes and genotype mixtures in HBV‐infected patients from Vietnam, Europe, and Africa.
Xinhua Fang, Mirjam B. Zeisel, Jochen Wilpert, Bettina Gissler, Robert Thimme, Clemens Kreutz, Thomas Maiwald, Jens Timmer, Winfried V. Kern, Johannes Donauer, Marcel Geyer, Gerd Walz, Erik Depla, Fritz von Weizsäcker, Hubert E. Blum, Thomas F. Baumert – 25 May 2006 – Initiation of hepatitis C virus (HCV) infection is mediated by docking of the viral envelope to the hepatocyte cell surface membrane followed by entry of the virus into the host cell.